18-62113140-T-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_176787.5(PIGN):c.1428A>T(p.Glu476Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,605,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PIGN | NM_176787.5 | c.1428A>T | p.Glu476Asp | missense_variant | 16/31 | ENST00000640252.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PIGN | ENST00000640252.2 | c.1428A>T | p.Glu476Asp | missense_variant | 16/31 | 1 | NM_176787.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 49AN: 236914Hom.: 0 AF XY: 0.000195 AC XY: 25AN XY: 128160
GnomAD4 exome AF: 0.000111 AC: 161AN: 1452858Hom.: 0 Cov.: 29 AF XY: 0.000125 AC XY: 90AN XY: 721942
GnomAD4 genome AF: 0.000125 AC: 19AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74464
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 04, 2020 | The c.1428A>T (p.E476D) alteration is located in exon 16 (coding exon 13) of the PIGN gene. This alteration results from an A to T substitution at nucleotide position 1428, causing the glutamic acid (E) at amino acid position 476 to be replaced by an aspartic acid (D). Based on data from the Genome Aggregation Database (gnomAD) database, the PIGN c.1428A>T alteration was observed in 0.02% (52/268304) of total alleles studied, with a frequency of 0.22% (22/10064) in the Ashkenazi Jewish subpopulation. This amino acid position is not well conserved in available vertebrate species. The p.E476D alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at